CompletedNot Applicable

Peer Mentorship to Reduce Suicide Attempts Among High-Risk Adults

United States455 participantsStarted 2018-06-22

Plain-language summary

This is a single-blind, randomized controlled trial to test the effectiveness of a peer mentorship intervention (PREVAIL) for reducing suicide risk compared to enhanced usual care among participants (N=455) at high-risk for suicide recruited from inpatient psychiatric units.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. are age 18 years or older,
✓. are currently admitted to an inpatient psychiatric unit and have medical record documentation of suicidal ideation or suicide attempt at the time of admission,
✓. have a Beck Suicide Scale score of 5 or higher for the 1-week period prior to admission,
✓. are fluent in English,
✓. are able to be reached reliably by telephone.

Exclusion criteria

✕. substantially cognitively impaired (according to the Mini-Cog),
✕. unable to provide informed consent for any reason (including incompetency),
✕. determined by the patient's attending psychiatrist that peer mentorship is not appropriate due to unstable psychosis, cognitive disorder, or severe personality disorder,
✕. already receiving or intending to receive peer mentorship (i.e., sponsor from Alcoholics Anonymous) or group-based peer support on a biweekly or more frequent basis,
✕. residing more than 50 miles from any peer mentor,
✕. planning to be discharged to another inpatient or residential facility, or
✕. receiving electroconvulsive therapy

What they're measuring

Suicide Attempts, as Measured by the Columbia Suicide Severity Rating Scale (CSSRS)

Timeframe: 3 months, 6 months

Suicidal Ideation (Current), as Measured by the Beck Suicide Scale (BSS)

Timeframe: 3 months, 6 months

Trial details

NCT IDNCT03373916

SponsorUniversity of Michigan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-30

Results submitted2024-10-02

View on ClinicalTrials.gov More Suicidal Ideation trials